{"id":16927,"date":"2024-08-05T12:20:07","date_gmt":"2024-08-05T10:20:07","guid":{"rendered":"https:\/\/immune.institute\/?p=16927"},"modified":"2024-08-05T12:20:07","modified_gmt":"2024-08-05T10:20:07","slug":"becas-tecnologia-personas-con-discapacidad","status":"publish","type":"post","link":"https:\/\/immune.institute\/en\/blog\/becas-tecnologia-personas-con-discapacidad\/","title":{"rendered":"Fundaci\u00f3n ONCE and IMMUNE Technology Institute join forces to promote technology training for people with disabilities"},"content":{"rendered":"

Fundaci\u00f3n ONCE, together with its entities Inserta Empleo and Inserta Innovaci\u00f3n, has signed a collaboration agreement with IMMUNE Technology Institute, hub <\/em>of technological talent, with the aim of promoting digital and technological skills training for people with disabilities<\/strong> and thus improve their employment opportunities <\/strong>and social inclusion.<\/p>\n\n\n\n

The agreement is based on the offer of grants for people with disabilities<\/a><\/strong> who are interested in taking the training programmes of the \"By Talento Digital<\/a><\/strong>\"for at least the next two years.<\/p>\n\n\n\n

In the training programmes on offer, scholarship holders will be able to find bootcamps <\/strong>o masters <\/strong>of different technological areas with high demand in the labour market such as: cloud computing<\/strong>, cybersecurity<\/strong>, data analytics<\/strong>, artificial intelligence <\/strong>o UX\/UI design<\/strong>. All of them with an employability rate of over 85%, according to data from the UGT report, \"Technological employment in the Spanish labour market 2024\".<\/p>\n\n\n\n

<\/p>\n\n\n\n

Technology grants for people with disabilities<\/h2>\n\n\n\n

The grants will cover up to 80% of the cost of the tuition fee<\/strong> in the training programmes, with a maximum of \u20ac10,000 per person. Those interested in applying for these scholarships can do so by contacting here<\/a>.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n


Technology can play a transformative role in the labour market, helping the integration of people with disabilities<\/strong>. As expressed by Juan Riva<\/strong>CEO and founder of IMMUNE Technology Institute, \"We at IMMUNE are excited to be part of this initiative which reflects our commitment to inclusion and fostering technology talent. We strongly believe in the importance of providing access to technology training<\/strong>This is an area with high employability rates, and this collaboration is a significant step towards a more inclusive and equitable future.<\/p>\n\n\n\n


For its part, Jos\u00e9 Luis Mart\u00ednez Donoso<\/strong>The Director General of the ONCE Foundation, expressed his satisfaction with the signing of this agreement, which aims to improving the digital skills of people with disabilities<\/strong>. \"The aim is to give them the necessary tools so that they can face the job offers of a labour market increasingly focused on digital profiles with a better chance of success.<\/p>","protected":false},"excerpt":{"rendered":"

Fundaci\u00f3n ONCE, junto a sus entidades Inserta Empleo e Inserta Innovaci\u00f3n, ha firmado un acuerdo de colaboraci\u00f3n con IMMUNE Technology Institute, hub de talento tecnol\u00f3gico, con el objetivo de promover la formaci\u00f3n en competencias digitales y tecnol\u00f3gicas entre las personas con discapacidad y mejorar as\u00ed sus oportunidades de empleo e inclusi\u00f3n social. El acuerdo se […]<\/p>\n","protected":false},"author":3,"featured_media":16928,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-16927","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"_links":{"self":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/posts\/16927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/comments?post=16927"}],"version-history":[{"count":0,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/posts\/16927\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/media\/16928"}],"wp:attachment":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/media?parent=16927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/categories?post=16927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/tags?post=16927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}